Noramco, founded in 1979 and headquartered in Delaware, is a leading specialty active pharmaceutical ingredient (API) development and manufacturing company with operations worldwide. Specializing in controlled substance development, they provide DEA compliant security and production capacity for a range of opioid and non-opioid products. With over a decade of experience in large-scale manufacture of nal family compounds and a commitment to addiction treatment and abuse prevention, Noramco offers high purity controlled substances and custom synthesis solutions to meet global regulatory requirements. Their expertise in ADHD technology and world-class supply security make them a trusted partner in the pharmaceutical industry. Generated from the website